281 related articles for article (PubMed ID: 21039536)
1. Themed issue: improve dissolution, solubility and bioavailability of poorly soluble drugs.
Perrie Y; Rades T
J Pharm Pharmacol; 2010 Nov; 62(11):1517-8. PubMed ID: 21039536
[No Abstract] [Full Text] [Related]
2. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Müller CE
Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
[TBL] [Abstract][Full Text] [Related]
3. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.
Kleberg K; Jacobsen J; Müllertz A
J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549
[TBL] [Abstract][Full Text] [Related]
4. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical applications of cyclodextrins: basic science and product development.
Loftsson T; Brewster ME
J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
[TBL] [Abstract][Full Text] [Related]
6. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
Blagden N; de Matas M; Gavan PT; York P
Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
Porter CJ; Wasan KM; Constantinides P
Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
[No Abstract] [Full Text] [Related]
8. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
Bunjes H
J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
[TBL] [Abstract][Full Text] [Related]
9. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
Kohli K; Chopra S; Dhar D; Arora S; Khar RK
Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
[TBL] [Abstract][Full Text] [Related]
10. Foreword for the JPP special issue 'Recent innovations in dissolution testing'.
Dressman J; Weitschies W
J Pharm Pharmacol; 2012 Jul; 64(7):909-10. PubMed ID: 22686338
[No Abstract] [Full Text] [Related]
11. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
12. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
[TBL] [Abstract][Full Text] [Related]
13. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
Müllertz A; Ogbonna A; Ren S; Rades T
J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
[TBL] [Abstract][Full Text] [Related]
14. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
15. Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.
Kleppe MS; Forney-Stevens KM; Haskell RJ; Bogner RH
AAPS J; 2015 Jul; 17(4):902-17. PubMed ID: 25851513
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in intravenous delivery of poorly water-soluble compounds.
Shi Y; Porter W; Merdan T; Li LC
Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
[TBL] [Abstract][Full Text] [Related]
17. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
18. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
[TBL] [Abstract][Full Text] [Related]
19. Self-nanoemulsifying powders for improved oral delivery of poorly water-soluble drugs.
Eedara BB; Kallakunta VR; Bandari S
Ther Deliv; 2015; 6(8):899-901. PubMed ID: 26488495
[No Abstract] [Full Text] [Related]
20. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
Yasuji T; Takeuchi H; Kawashima Y
Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]